+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Stem Cell Banking Market - Global Forecast to 2030- Product Image
Stem Cell Banking Market - Global Forecast to 2030- Product Image
Sale

Stem Cell Banking Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012128
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Stem Cell Banking Market grew from USD 16.98 billion in 2024 to USD 20.03 billion in 2025. It is expected to continue growing at a CAGR of 17.33%, reaching USD 44.32 billion by 2030.

The stem cell banking industry stands at a pivotal crossroads. Fueled by breakthroughs in regenerative medicine and personalized therapies, the sector is witnessing unprecedented interest from healthcare providers, research institutions, and end users alike. Advances in cryopreservation techniques, coupled with an expanding understanding of stem cell biology, have transformed once-nascent concepts into viable clinical applications. As emerging technologies reduce costs and elevate safety standards, more families and medical centers are exploring biobanking solutions for hematopoietic, neurological, and cardiovascular therapies. In parallel, regulatory bodies are crafting frameworks to ensure ethical sourcing, quality control, and traceability, reinforcing confidence across global markets. This executive summary distills the critical drivers, market dynamics, and strategic imperatives shaping the next phase of growth. By unpacking shifting market forces, analyzing the cumulative impact of new US tariffs in 2025, and spotlighting segmentation and regional nuances, we provide a clear roadmap for decision-makers seeking to navigate complexity with clarity. Our goal is to equip industry leaders with actionable insights-illuminating where value is created, how challenges can be mitigated, and why proactive strategies will define the leaders of tomorrow’s stem cell banking landscape.

Transformative Shifts Redefining Stem Cell Banking Dynamics

In recent years, transformative shifts have redefined the stem cell banking landscape. Technological innovation now enables higher viability rates through next-generation cryoprotectants and automated storage systems, driving down operational costs and increasing throughput. Simultaneously, digital platforms are streamlining donor enrollment and consent management, delivering unprecedented transparency and reducing administrative bottlenecks. On the regulatory front, harmonization efforts across North America, Europe, and Asia-Pacific have lowered barriers to cross-border sample transfers, empowering multinational service providers. At the same time, growing patient awareness-fueled by breakthroughs in personalized medicine-has accelerated demand for both private and public banking solutions. Strategic partnerships between biobanks and academic or corporate research centers are unlocking novel applications in immuno-oncology and tissue engineering, laying the groundwork for next-wave therapies. Amid these dynamic forces, hybrid bank models-combining aspects of public and private operations-are emerging as a resilient approach to maximize utilization and diversify revenue streams. As these trends coalesce, organizations that embrace digital transformation, cultivate scientific collaborations, and proactively engage with evolving regulations will capture disproportionate market share.

Assessing the Cumulative Impact of US Tariffs in 2025

The introduction of new US tariffs in early 2025 has exerted a multifaceted influence on the global stem cell banking ecosystem. Increased duties on imported reagents, specialized storage equipment, and genome-editing tools have elevated input costs for both domestic and international operators. Supply chain disruptions-manifesting as extended lead times for critical consumables-have compelled several biobanks to source materials from alternative markets or to accelerate local manufacturing partnerships. In response to the shifting cost base, many organizations have initiated targeted price adjustments while simultaneously optimizing inventory management practices to mitigate working capital strains. At the same time, some providers are leveraging domestic R&D credits and expedited regulatory pathways to develop proprietary consumables that reduce reliance on tariff-affected imports. These adaptive strategies have not only preserved service continuity but also fostered deeper collaborations between US-based manufacturers and global distributors. As tariff environments remain fluid, stakeholders that maintain agile sourcing models and pursue vertical integration opportunities will be better positioned to absorb cost pressures and sustain competitive margins.

Key Segmentation Insights Across Cell Types, Sources, Bank Models, Applications, and Users

In-depth segmentation analysis reveals distinct pockets of opportunity across cell type, source, bank model, application, and end-user. The market for adult stem cells-particularly hematopoietic and mesenchymal subtypes-continues to command significant interest owing to established safety profiles and proven efficacy. Embryonic stem cells, differentiated into pluripotent and totipotent classes, hold promise for broader regenerative therapies but face ethical and regulatory headwinds. Induced pluripotent stem cells generated from blood cells and fibroblasts are emerging as a versatile alternative, enabling patient-specific applications without the controversies of embryonic lines. Source-based dynamics underscore the expanding role of adipose tissue, harvested from both subcutaneous and visceral fat, in therapeutic pipelines. Bone marrow remains a gold standard, drawn primarily from the iliac crest but increasingly supplemented by tibial extractions. Cord blood banking now extends beyond umbilical cord samples to include placental blood, enhancing both yield and genetic diversity. In terms of bank model, hybrid operations blending public and private frameworks, as well as cooperative membership models, offer scalability with cost efficiencies. Traditional private banks-spanning family-owned and for-profit institutions-cater to high-net-worth segments, while government-managed and non-profit public banks serve broader community health objectives. Application areas span hematopoietic disorders like leukemia and thalassemia, neurological conditions such as multiple sclerosis and Parkinson’s disease, and regenerative medicine fields focused on cardiovascular and orthopedic treatments. On the demand side, general and specialized hospitals collaborate with academic and corporate research labs, alongside cosmetic surgery and fertility clinics, to expand the reach of stem cell services across both clinical and elective settings.

Regional Nuances Shaping Global Stem Cell Banking Strategies

Regional markets exhibit unique drivers and constraints, shaping tailored strategies for market entry and expansion. In the Americas, legacy infrastructure within the US supports advanced biobanking operations, underpinned by robust private banking uptake and sizable research funding from public institutions. Latin American nations are increasingly investing in public bank networks to broaden community access, leveraging partnerships with established global operators. Europe, Middle East & Africa present a mosaic of frameworks: Western Europe’s reimbursement policies and stringent quality standards foster premium service offerings, while emerging hubs in the Middle East prioritize public-private alliances to kickstart local capacity. Across Africa, pilot programs in urban centers are laying the groundwork for wider adoption despite logistical challenges. In Asia-Pacific, China’s biotech investment surge fuels rapid scale-up of domestic banks, whereas Japan’s leadership in induced pluripotent stem cell research accelerates novel therapeutic launches. India’s expansive cord blood banking sector, augmented by competitive pricing and a vast donor pool, positions it as a high-growth market. Meanwhile, Australia and Southeast Asian economies focus on regulatory alignment and cross-border clinical collaborations to capture incremental value from neighboring markets.

Strategic Profiles of Leading Stem Cell Banking Companies

A diverse array of market participants drives innovation, service excellence, and strategic expansion. Amag Pharmaceuticals and PerkinElmer deliver cutting-edge cryopreservation reagents and analytical platforms that enhance viability and monitoring. Cord-centric custodians such as Americord Registry, Cord Blood America, Cordlife Sciences India, CordVida, Cryo-Cell International, CryoHoldco de Latinoamerica S.A.P.I. de C.V., Cryoviva Biotech, Global Cord Blood Corporation, and LifeCell International have built extensive donor networks and global storage facilities to support both private and public needs. Breakthrough therapy developers including BrainStorm Cell Therapeutics, Cellectis SA, and Human Longevity are pioneering clinical applications in neurodegenerative and hematopoietic disorders, translating banked samples into next-generation treatments. Specialized service providers like Lifeforce Cryobank Sciences integrate partnerships with cosmetic surgery clinics and fertility centers to widen consumer access. Together, these organizations exemplify leadership in operational resilience, technological differentiation, and collaborative ecosystems. As competition intensifies, the ability to fuse core competencies-such as proprietary processing protocols, regulatory expertise, and global distribution networks-will determine sustained market leadership.

Actionable Recommendations for Industry Leaders in Stem Cell Banking

To secure a competitive edge, industry leaders should pursue a multi-pronged strategy. First, integrate advanced cryopreservation techniques and digital chain-of-custody tracking to guarantee sample integrity and regulatory compliance. Second, diversify cell sourcing-balancing adipose, bone marrow, and cord blood streams-to mitigate supply risk and address varied therapeutic pipelines. Third, cultivate strategic alliances across academia, contract research organizations, and technology vendors to accelerate clinical translation and broaden service portfolios. Fourth, explore hybrid bank models that combine subscription-based private offerings with community-oriented public services, optimizing utilization and unlocking new revenue channels. Fifth, proactively engage with policy makers to shape pragmatic regulations that balance safety with innovation. Sixth, strengthen supply chain resilience by developing local manufacturing partnerships or in-house production capabilities, thereby insulating operations from tariff volatility. Finally, invest in targeted marketing and patient outreach programs that educate stakeholders on the value proposition of stem cell banking, converting awareness into enrollment and retention.

Conclusion: Navigating the Future of Stem Cell Banking

The stem cell banking sector is poised for dynamic expansion, driven by scientific breakthroughs, evolving regulations, and shifting market demand. Key segmentation and regional analyses reveal that success hinges on adaptability-whether through technological differentiation, diversified business models, or strategic partnerships. The 2025 tariff landscape underscores the importance of supply chain agility and domestic sourcing capabilities. Leading companies are those that anticipate change, engage collaboratively with regulators, and align their offerings with emerging clinical needs. By executing the recommendations outlined here, organizations can elevate service quality, optimize cost structures, and capture new growth opportunities across global markets. It is through this proactive stance-coupled with rigorous operational discipline and a clear customer-centric focus-that industry leaders will define the next frontier of regenerative medicine and personalized healthcare.

Market Segmentation & Coverage

This research report categorizes the Stem Cell Banking Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Adult Stem Cells
    • Hematopoietic Stem Cells
    • Mesenchymal Stem Cells
  • Embryonic Stem Cells
    • Pluripotent
    • Totipotent
  • Induced Pluripotent Stem Cells
    • Generated From Blood Cells
    • Generated From Fibroblasts
  • Adipose Tissue
    • Subcutaneous Fat
    • Visceral Fat
  • Bone Marrow
    • Iliac Crest
    • Tibial
  • Cord Blood
    • Placenta Blood
    • Umbilical Cord Blood
  • Hybrid Banks
    • Combination of Public and Private
    • Cooperative Models
  • Private Banks
    • Family Owned
    • For-Profit Institutions
  • Public Banks
    • Government-Managed
    • Non-Profit Organizations
  • Hematopoietic Disorders
    • Leukemia
    • Thalassemia
  • Neurological Disorders
    • Multiple Sclerosis
    • Parkinson's Disease
  • Regenerative Medicine
    • Cardiovascular Treatments
    • Orthopedic Treatments
  • Hospitals
    • General Hospitals
    • Specialized Hospitals
  • Research Institutions
    • Academic Research
    • Corporate Research Labs
  • Specialized Clinics
    • Cosmetic Surgery Clinics
    • Fertility Clinics

This research report categorizes the Stem Cell Banking Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Stem Cell Banking Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Amag Pharmaceuticals, Inc.
  • Americord Registry LLC
  • BrainStorm Cell Therapeutics, Inc.
  • Cellectis SA
  • Cord Blood America, Inc.
  • Cordlife Sciences India Pvt. Ltd.
  • CordVida
  • Cryo-Cell International, Inc.
  • CryoHoldco de Latinoamerica, S.A.P.I. de C.V.
  • Cryoviva Biotech Private Limited
  • Global Cord Blood Corporation
  • Human Longevity, Inc
  • LifeCell International Private Limited
  • Lifeforce Cryobank Sciences, Inc.
  • PerkinElmer, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Stem Cell Banking Market, by Type of Stem Cells
8.1. Introduction
8.2. Adult Stem Cells
8.2.1. Hematopoietic Stem Cells
8.2.2. Mesenchymal Stem Cells
8.3. Embryonic Stem Cells
8.3.1. Pluripotent
8.3.2. Totipotent
8.4. Induced Pluripotent Stem Cells
8.4.1. Generated From Blood Cells
8.4.2. Generated From Fibroblasts
9. Stem Cell Banking Market, by Source of Stem Cells
9.1. Introduction
9.2. Adipose Tissue
9.2.1. Subcutaneous Fat
9.2.2. Visceral Fat
9.3. Bone Marrow
9.3.1. Iliac Crest
9.3.2. Tibial
9.4. Cord Blood
9.4.1. Placenta Blood
9.4.2. Umbilical Cord Blood
10. Stem Cell Banking Market, by Bank Type
10.1. Introduction
10.2. Hybrid Banks
10.2.1. Combination of Public and Private
10.2.2. Cooperative Models
10.3. Private Banks
10.3.1. Family Owned
10.3.2. For-Profit Institutions
10.4. Public Banks
10.4.1. Government-Managed
10.4.2. Non-Profit Organizations
11. Stem Cell Banking Market, by Application
11.1. Introduction
11.2. Hematopoietic Disorders
11.2.1. Leukemia
11.2.2. Thalassemia
11.3. Neurological Disorders
11.3.1. Multiple Sclerosis
11.3.2. Parkinson's Disease
11.4. Regenerative Medicine
11.4.1. Cardiovascular Treatments
11.4.2. Orthopedic Treatments
12. Stem Cell Banking Market, by End-User
12.1. Introduction
12.2. Hospitals
12.2.1. General Hospitals
12.2.2. Specialized Hospitals
12.3. Research Institutions
12.3.1. Academic Research
12.3.2. Corporate Research Labs
12.4. Specialized Clinics
12.4.1. Cosmetic Surgery Clinics
12.4.2. Fertility Clinics
13. Americas Stem Cell Banking Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Stem Cell Banking Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Stem Cell Banking Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Amag Pharmaceuticals, Inc.
16.3.2. Americord Registry LLC
16.3.3. BrainStorm Cell Therapeutics, Inc.
16.3.4. Cellectis SA
16.3.5. Cord Blood America, Inc.
16.3.6. Cordlife Sciences India Pvt. Ltd.
16.3.7. CordVida
16.3.8. Cryo-Cell International, Inc.
16.3.9. CryoHoldco de Latinoamerica, S.A.P.I. de C.V.
16.3.10. Cryoviva Biotech Private Limited
16.3.11. Global Cord Blood Corporation
16.3.12. Human Longevity, Inc
16.3.13. LifeCell International Private Limited
16.3.14. Lifeforce Cryobank Sciences, Inc.
16.3.15. PerkinElmer, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. STEM CELL BANKING MARKET MULTI-CURRENCY
FIGURE 2. STEM CELL BANKING MARKET MULTI-LANGUAGE
FIGURE 3. STEM CELL BANKING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL STEM CELL BANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL STEM CELL BANKING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL STEM CELL BANKING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. STEM CELL BANKING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. STEM CELL BANKING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. STEM CELL BANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL STEM CELL BANKING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL STEM CELL BANKING MARKET SIZE, BY MESENCHYMAL STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL STEM CELL BANKING MARKET SIZE, BY PLURIPOTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL STEM CELL BANKING MARKET SIZE, BY TOTIPOTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL STEM CELL BANKING MARKET SIZE, BY GENERATED FROM BLOOD CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL STEM CELL BANKING MARKET SIZE, BY GENERATED FROM FIBROBLASTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL STEM CELL BANKING MARKET SIZE, BY SUBCUTANEOUS FAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL STEM CELL BANKING MARKET SIZE, BY VISCERAL FAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL STEM CELL BANKING MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL STEM CELL BANKING MARKET SIZE, BY ILIAC CREST, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL STEM CELL BANKING MARKET SIZE, BY TIBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL STEM CELL BANKING MARKET SIZE, BY PLACENTA BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL STEM CELL BANKING MARKET SIZE, BY UMBILICAL CORD BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL STEM CELL BANKING MARKET SIZE, BY COMBINATION OF PUBLIC AND PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL STEM CELL BANKING MARKET SIZE, BY COOPERATIVE MODELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL STEM CELL BANKING MARKET SIZE, BY FAMILY OWNED, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL STEM CELL BANKING MARKET SIZE, BY FOR-PROFIT INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL STEM CELL BANKING MARKET SIZE, BY GOVERNMENT-MANAGED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL STEM CELL BANKING MARKET SIZE, BY NON-PROFIT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL STEM CELL BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL STEM CELL BANKING MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL STEM CELL BANKING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL STEM CELL BANKING MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL STEM CELL BANKING MARKET SIZE, BY CARDIOVASCULAR TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL STEM CELL BANKING MARKET SIZE, BY ORTHOPEDIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL STEM CELL BANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL STEM CELL BANKING MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL STEM CELL BANKING MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL STEM CELL BANKING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL STEM CELL BANKING MARKET SIZE, BY CORPORATE RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL STEM CELL BANKING MARKET SIZE, BY COSMETIC SURGERY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL STEM CELL BANKING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 132. CANADA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 133. CANADA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 134. CANADA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 135. CANADA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 136. CANADA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 137. CANADA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 138. CANADA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 139. CANADA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 140. CANADA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 141. CANADA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 142. CANADA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 143. CANADA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 144. CANADA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. CANADA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 146. CANADA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 147. CANADA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 148. CANADA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. CANADA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. CANADA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 151. CANADA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 158. MEXICO STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 159. MEXICO STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 160. MEXICO STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 162. MEXICO STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. MEXICO STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 166. MEXICO STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. MEXICO STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES STEM CELL BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC STEM CELL BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 234. CHINA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 235. CHINA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 236. CHINA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 237. CHINA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 238. CHINA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 239. CHINA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 240. CHINA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 241. CHINA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 242. CHINA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 243. CHINA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 244. CHINA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 245. CHINA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 246. CHINA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. CHINA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 248. CHINA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 249. CHINA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 250. CHINA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. CHINA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. CHINA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 253. CHINA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 254. INDIA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 255. INDIA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 256. INDIA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 257. INDIA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 258. INDIA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 259. INDIA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 260. INDIA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 261. INDIA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 262. INDIA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 263. INDIA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 264. INDIA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 265. INDIA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 266. INDIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. INDIA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 268. INDIA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 269. INDIA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 270. INDIA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. INDIA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. INDIA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 273. INDIA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 297. JAPAN STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 298. JAPAN STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 299. JAPAN STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 300. JAPAN STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 301. JAPAN STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 302. JAPAN STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 303. JAPAN STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 304. JAPAN STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 305. JAPAN STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 306. JAPAN STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. JAPAN STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 308. JAPAN STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 309. JAPAN STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 310. JAPAN STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 311. JAPAN STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. JAPAN STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 313. JAPAN STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 320. MALAYSIA STEM CELL BANKING MARKET SIZE, BY BONE MARROW, 2018-2030 (USD MILLION)
TABLE 321. MALAYSIA STEM CELL BANKING MARKET SIZE, BY CORD BLOOD, 2018-2030 (USD MILLION)
TABLE 322. MALAYSIA STEM CELL BANKING MARKET SIZE, BY BANK TYPE, 2018-2030 (USD MILLION)
TABLE 323. MALAYSIA STEM CELL BANKING MARKET SIZE, BY HYBRID BANKS, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA STEM CELL BANKING MARKET SIZE, BY PRIVATE BANKS, 2018-2030 (USD MILLION)
TABLE 325. MALAYSIA STEM CELL BANKING MARKET SIZE, BY PUBLIC BANKS, 2018-2030 (USD MILLION)
TABLE 326. MALAYSIA STEM CELL BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. MALAYSIA STEM CELL BANKING MARKET SIZE, BY HEMATOPOIETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 328. MALAYSIA STEM CELL BANKING MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 329. MALAYSIA STEM CELL BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, 2018-2030 (USD MILLION)
TABLE 330. MALAYSIA STEM CELL BANKING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA STEM CELL BANKING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA STEM CELL BANKING MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA STEM CELL BANKING MARKET SIZE, BY SPECIALIZED CLINICS, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY TYPE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY ADULT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY EMBRYONIC STEM CELLS, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY SOURCE OF STEM CELLS, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY ADIPOSE TISSUE, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES STEM CELL BANKING MARKET SIZE, BY BO

Companies Mentioned

  • Amag Pharmaceuticals, Inc.
  • Americord Registry LLC
  • BrainStorm Cell Therapeutics, Inc.
  • Cellectis SA
  • Cord Blood America, Inc.
  • Cordlife Sciences India Pvt. Ltd.
  • CordVida
  • Cryo-Cell International, Inc.
  • CryoHoldco de Latinoamerica, S.A.P.I. de C.V.
  • Cryoviva Biotech Private Limited
  • Global Cord Blood Corporation
  • Human Longevity, Inc
  • LifeCell International Private Limited
  • Lifeforce Cryobank Sciences, Inc.
  • PerkinElmer, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Cell Banking Outsourcing Market by Type, Cell Type, Phase - Global Forecast 2025-2030 - Product Image

Cell Banking Outsourcing Market by Type, Cell Type, Phase - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Stem Cell Banking - Global Strategic Business Report - Product Image

Stem Cell Banking - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From
Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032 - Product Image

Stem Cell Banking Market Report by Product Type, Service Type, Bank Type, Utilization, Application, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
GMP Cell Banking Services Market by Cell Type (Animal Cells, Human Cells), Quality Grade (Clinical Grade, Research Grade), Service Type, Application, End-User - Global Forecast 2025-2030 - Product Image

GMP Cell Banking Services Market by Cell Type (Animal Cells, Human Cells), Quality Grade (Clinical Grade, Research Grade), Service Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Cell Banking Outsourcing - Global Strategic Business Report - Product Image

Cell Banking Outsourcing - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From

About the Stem Cell Biobanking Market

The Stem Cell Biobanking market is a specialized sector of the stem cell industry. It involves the collection, storage, and distribution of stem cells for research and therapeutic purposes. Stem cell biobanking is a critical component of the stem cell industry, as it provides a reliable source of stem cells for research and clinical applications. Stem cell biobanks are responsible for collecting, processing, and storing stem cells from a variety of sources, including umbilical cord blood, bone marrow, and adipose tissue. These stem cells are then used for research and therapeutic purposes, such as regenerative medicine and drug development. Some of the major players in the Stem Cell Biobanking market include Cryo-Cell International, Cord Blood Registry, StemCyte, and ViaCord. These companies provide a range of services, including stem cell collection, processing, storage, and distribution. Additionally, they offer a variety of products, such as stem cell banking kits, stem cell banking services, and stem cell banking software. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.